Crossmark

Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility

Crossref DOI link: https://doi.org/10.1186/s13073-019-0640-z

Published Online: 2019-04-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Afrasiabi, Ali

Parnell, Grant P.

Fewings, Nicole

Schibeci, Stephen D.

Basuki, Monica A.

Chandramohan, Ramya

Zhou, Yuan

Taylor, Bruce

Brown, David A.

Swaminathan, Sanjay

McKay, Fiona C.

Stewart, Graeme J.

Booth, David R. https://orcid.org/0000-0001-8580-2384
Funding

Funding for this research was provided by:

MSIF (NA)

National Health and Medical Research Council (1078494, 1065157)

Multiple Sclerosis Research Australia (NA, NA, NA)
License Information

Text and Data Mining valid from 2019-04-30
More Information

Article History

Received: 28 October 2018

Accepted: 10 April 2019

First Online: 30 April 2019

Ethics approval and consent to participate

: All blood samples were collected from healthy controls with informed consent (Westmead Hospital Human Research Ethics Committee Approval 1425) and in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.